SG Americas Securities’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,940
| Closed | -$203K | – | 3002 |
|
|
2024
Q4 | $203K | Buy |
11,940
+3,705
| +45% | +$63K | ﹤0.01% | 1891 |
|
|
2024
Q3 | $191K | Buy |
+8,235
| New | +$191K | ﹤0.01% | 2255 |
|
|
2024
Q2 | – | Sell |
-8,758
| Closed | -$296K | – | 2416 |
|
|
2024
Q1 | $296K | Sell |
8,758
-24,520
| -74% | -$829K | ﹤0.01% | 1512 |
|
|
2023
Q4 | $1.05M | Sell |
33,278
-42,567
| -56% | -$1.34M | 0.01% | 888 |
|
|
2023
Q3 | $1.94M | Buy |
+75,845
| New | +$1.94M | 0.02% | 692 |
|
|
2023
Q2 | – | Sell |
-10,086
| Closed | -$242K | – | 1956 |
|
|
2023
Q1 | $242K | Buy |
+10,086
| New | +$242K | ﹤0.01% | 2085 |
|
|
2022
Q3 | – | Sell |
-22,678
| Closed | -$357K | – | 2782 |
|
|
2022
Q2 | $357K | Buy |
+22,678
| New | +$357K | ﹤0.01% | 2042 |
|
|
2022
Q1 | – | Sell |
-5,965
| Closed | -$221K | – | 2572 |
|
|
2021
Q4 | $221K | Sell |
5,965
-8,802
| -60% | -$326K | ﹤0.01% | 2361 |
|
|
2021
Q3 | $706K | Buy |
+14,767
| New | +$706K | ﹤0.01% | 2032 |
|
|
2021
Q2 | – | Sell |
-7,355
| Closed | -$304K | – | 2499 |
|
|
2021
Q1 | $304K | Buy |
+7,355
| New | +$304K | ﹤0.01% | 2146 |
|
|
2020
Q4 | – | Sell |
-17,931
| Closed | -$769K | – | 2787 |
|
|
2020
Q3 | $769K | Buy |
17,931
+10,551
| +143% | +$452K | ﹤0.01% | 1117 |
|
|
2020
Q2 | $345K | Buy |
+7,380
| New | +$345K | ﹤0.01% | 2072 |
|